Kristy Thom
@Marquette Asset Management, Llc
Latest period2024 - Q4ReportedManaged Assets$612.724MTotal holdings190
Assets growth rate-2.85%Assets growth rate (2-Q avg)2.17%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Marquette Asset Management, Llc's 2024 - Q4 portfolio, based on their 13F SEC filing, out of a total of 190 positions.
Assets under management
The assets under management (AUM) of Marquette Asset Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q4, they manage 612.724M in assets, with a quarterly growth rate of -2.85% and a 2-quarter average growth rate of 2.17%. The portfolio is managed by Kristy Thom, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SCHASchwab Strategic Tr
| 1.09% | $6.645M 256,971 shares@ $25.87 avg price | Increased 98.54% |
SCHMSchwab Strategic Tr
| 0.45% | $2.756M 99,468 shares@ $27.72 avg price | Increased 198.91% |
SCHFSchwab Strategic Tr
| 0.34% | $2.047M 110,675 shares@ $18.51 avg price | Increased 96.43% |
SCHVSchwab Strategic Tr
| 0.13% | $750,034 28,770 shares@ $26.08 avg price | Increased 200% |
CATOCato Corp New
| 0.06% | $326,801 83,795 shares@ $3.91 avg price | Increased 9.2% |
FLGTFulgent Genetics Inc
| 0.05% | $291,402 15,777 shares@ $18.48 avg price | Increased 59.24% |
VRAVera Bradley Inc
| 0.05% | $262,481 66,789 shares@ $3.94 avg price | Increased 50.41% |
OSUROrasure Technologies Inc
| 0.05% | $250,336 69,345 shares@ $3.62 avg price | Increased 44.42% |
IVACIntevac Inc
| 0.04% | $225,329 66,273 shares@ $3.41 avg price | Increased 28.98% |
ANTXAn2 Therapeutics Inc
| 0.02% | $114,825 83,206 shares@ $1.39 avg price | Increased 29% |